Literature DB >> 22173735

PCI ad hoc or PCI at an interval: a risk calculation.

Sebastian Kohl, Otmar Pachinger, Bernhard Metzler.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22173735     DOI: 10.1007/s00392-011-0399-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  3 in total

1.  The 2010 ESC/EACTS guidelines on myocardial revascularisation.

Authors:  David P Taggart; Roger Boyle; Mark A de Belder; Keith A A Fox
Journal:  Heart       Date:  2010-12-14       Impact factor: 5.994

2.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

3.  Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience.

Authors:  A A Khattab; M Abdel-Wahab; C Röther; B Liska; R Toelg; G Kassner; V Geist; G Richardt
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460

  3 in total
  1 in total

1.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.